Who Is Eligible for RSV Vaccine Right Now?

Respiratory syncytial virus (RSV) causes lung and breathing infections, especially in young children and older adults. Each year, RSV leads to thousands of hospitalizations and can be serious in certain groups. Fortunately, new RSV vaccines and treatments have expanded preventive options. Here’s a clear overview of who is eligible for the RSV vaccine today, based on recommendations from the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA).

---

1. Adults 60 Years and Older

The FDA has approved two RSV vaccines for use in adults age 60 and up. The CDC recommends a single dose of one of these vaccines each RSV season, ideally given before RSV activity begins in your community.

Who should get it?

• All adults 60 years and older, regardless of overall health.
• Adults 60+ with chronic medical conditions, including:
  • Heart disease (e.g., heart failure)
  • Lung disease (e.g., chronic obstructive pulmonary disease, asthma)
  • Kidney or liver disorders
  • Diabetes mellitus
  • Weakened immune systems (due to illness or medications)
  • Neuromuscular disorders that make coughing or clearing secretions difficult

Why get vaccinated?

• RSV can lead to pneumonia, bronchitis or the need for hospitalization.
• Preventing RSV can reduce the risk of severe illness, especially if you have underlying health issues.

---

2. Pregnant People (32–36 Weeks of Gestation)

Maternal immunization helps protect newborns in their first months of life, when they’re most vulnerable and too young to be vaccinated themselves.

Who is eligible?

• Expectant parents between 32 weeks, 0 days and 36 weeks, 6 days of pregnancy.
• This single-dose vaccine is given once per pregnancy, ideally before RSV season starts.

Benefits for baby

• Antibodies from the vaccinated parent cross the placenta.
• Newborns gain temporary protection during their first 6 months, when RSV risk is high.

---

3. Infants and Young Children

Vaccines for infants differ from those for adults. Currently, the main preventive therapy for infants is a long-acting monoclonal antibody (mAb), nirsevimab (brand name: Beyfortus), which functions like a vaccine.

Healthy Infants Under 8 Months

• All infants younger than 8 months at the start of RSV season are eligible.
• A single dose before or during the season provides protection through the peak months.

Infants 8–19 Months at Increased Risk

• Infants and toddlers 8 through 19 months with certain risk factors, such as:
  • Chronic lung disease of prematurity
  • Severe immunocompromise
  • Hemodynamically significant congenital heart disease
  • Neuromuscular disorders
  • Cystic fibrosis with severe lung disease

---

4. Special Populations and Considerations

• People with weakened immune systems of any age
• Those planning to enter a long‐term care facility
• Individuals with multiple chronic conditions

Discuss with your healthcare provider if you fall into any of these categories. They will help you weigh benefits and timing.

---

5. Timing and Seasonality

RSV season usually runs from late fall through early spring, though exact timing varies by region. The goal is to vaccinate or give prophylactic antibodies before RSV begins to circulate heavily.

• Adults and pregnant people: ideally by early fall.
• Infants and young children: one dose just prior to or soon after RSV season onset.

---

6. How to Get Vaccinated

1. Talk to Your Doctor or Pharmacist
   Ask about RSV vaccination or prophylactic antibodies. They’ll review your age, health conditions and ideal timing.
2. Check Your Insurance
   Most private insurers and Medicare cover the RSV vaccine for eligible adults and monoclonal antibodies for at-risk infants.
3. Visit an Authorized Location
   Vaccines are available at primary care offices, obstetric clinics, pharmacies and some community health centers.

---

7. Monitoring for Side Effects

Like any vaccine, RSV shots can cause mild side effects:

• Soreness, redness or swelling at the injection site
• Low-grade fever
• Muscle aches or fatigue

These generally resolve within a few days. Serious reactions are rare—but if you experience difficulty breathing, chest pain or signs of an allergic reaction (such as hives or swelling of the face), seek medical care immediately.

---

8. Staying Vigilant During RSV Season

Vaccination is a powerful tool, but you can also reduce risk by:

• Washing hands frequently with soap and water
• Avoiding close contact with sick people
• Cleaning and disinfecting surfaces regularly
• Covering coughs and sneezes with a tissue or your elbow

If you or a family member develop cough, fever or difficulty breathing, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to guide your next steps: https://ubiehealth.com/

---

9. When to See a Doctor

While most RSV cases are mild, certain symptoms warrant prompt medical attention:

• Severe or worsening cough
• High fever not responding to fever reducers
• Trouble breathing or rapid breathing
• Bluish lips or fingernails
• Lethargy or difficulty waking

Always speak to a doctor about anything that could be life threatening or serious. Your healthcare provider can advise on treatments, hospital care if needed and follow-up.

---

10. Key Takeaways: Who Is Eligible for RSV Vaccine?

• Adults 60+: One dose of RSV vaccine per season.
• Pregnant people (32–36 weeks): One dose to protect newborns.
• Infants <8 months: Single dose of nirsevimab before RSV season.
• Infants 8–19 months at high risk: Single dose of nirsevimab.
• High-risk individuals: Discuss with your provider.

Vaccination and prophylactic antibodies reduce the burden of RSV in vulnerable groups. If you fall into any of the eligible categories, talk to your healthcare provider about timing and coverage. Stay informed, get protected and keep an eye on symptoms—using tools like the Ubie Symptom Checker when needed—and always reach out for medical advice for serious or life-threatening concerns.